Exploring How Cannabis and Psilocybin Could Benefit the 50 Million Americans Living with Chronic Pain Leave a comment
In late April 2024, the U.S. Drug Enforcement Administration revealed plans to relax federal regulations on cannabis by reclassifying it from Schedule I to Schedule III. This change aligns cannabis with medications like Tylenol with codeine, testosterone, and other anabolic steroids, marking a significant recognition of cannabis’s potential medicinal benefits.
About the Author
Our deep love of plants and fascination with Cannabis has enabled over 25 years of successful small-scale Marijuana cultivation from indoor hydroponics, greenhouses, and outdoor growing set-ups.
As Cannabis laws around the world change, *we support the movement toward freedom of choice for responsible, consenting adults who wish to experience the joy and wonder of growing a Cannabis plant.
